These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 28719435

  • 21. Methotrexate related cutaneous vasculitis.
    Torner O, Ruber C, Olive A, Tena X.
    Clin Rheumatol; 1997 Jan; 16(1):108-9. PubMed ID: 9132315
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cutaneous Vasculitis in a Patient with Crohn's Disease Treated with Adalimumab.
    Cury DB, de Souza AW, Vianna GA, Odashiro D, Farias A, Moss AC.
    Inflamm Bowel Dis; 2017 Jan; 23(1):E1-E2. PubMed ID: 27893546
    [No Abstract] [Full Text] [Related]

  • 24. DADS neuropathy associated with anti-TNF-α therapy.
    McGinty RN, McNamara B, Moore H.
    BMJ Case Rep; 2015 Nov 25; 2015():. PubMed ID: 26607186
    [Abstract] [Full Text] [Related]

  • 25. Alopecia universalis in a patient with rheumatoid arthritis developed during treatment with adalimumab.
    Ostojic P, Pavlov-Dolijanovic S.
    Z Rheumatol; 2018 Jun 25; 77(5):412-415. PubMed ID: 29744570
    [Abstract] [Full Text] [Related]

  • 26. [Antineutrophil cytoplasmic antibody associated vasculitis in a patient treated with adalimumab for a rheumatoid arthritis].
    Fournier A, Nony A, Rifard K.
    Nephrol Ther; 2009 Dec 25; 5(7):652-7. PubMed ID: 19482531
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Palmoplantar subcorneal pustular dermatosis following adalimumab therapy for rheumatoid arthritis.
    Sauder MB, Glassman SJ.
    Int J Dermatol; 2013 May 25; 52(5):624-8. PubMed ID: 23489057
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Adalimumab-induced central nervous system demyelination in a patient with rheumatoid arthritis.
    Shirah B, Altwirgi S, Faridoon I, Alghamdi S.
    Neuroradiol J; 2024 Apr 25; 37(2):234-236. PubMed ID: 37125695
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Comparison of the clinical characteristics of vasculitis occurring during anti-tumor necrosis factor treatment or not in rheumatoid arthritis patients. A systematic review of 2707 patients, 18 vasculitis.
    Guignard S, Gossec L, Bandinelli F, Dougados M.
    Clin Exp Rheumatol; 2008 Apr 25; 26(3 Suppl 49):S23-9. PubMed ID: 18799049
    [Abstract] [Full Text] [Related]

  • 40. Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects.
    Xue Y, Cohen JM, Wright NA, Merola JF.
    Am J Clin Dermatol; 2016 Apr 25; 17(2):147-62. PubMed ID: 26649439
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.